REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Gm Pharma Sdn. Bhd. (Malaysia)

Main Activities: Pharmacies and Drug Stores
Full name: Gm Pharma Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Gm Pharma Sdn. Bhd. is based in Malaysia, with the head office in Gua Musang. The enterprise operates in the Pharmacies and Drug Stores industry. It was incorporated on September 24, 2020. There was a net sales revenue increase of 15.15% reported in Gm Pharma Sdn. Bhd.’s latest financial highlights for 2023. Its’ total assets recorded a growth of 13.49%. In 2023, Gm Pharma Sdn. Bhd.’s net profit margin increased by 0.82%.

Headquarters
Lot 18189, (Pt 13472), Taman Sri Chindai
Gua Musang; Kelantan; Postal Code: 18300

Contact Details: Purchase the Gm Pharma Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Gm Pharma Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Gm Pharma Sdn. Bhd. report to view the information.
Incorporation Date:
September 24, 2020
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
95%
Purchase this report to view the information.
5%
Company Performance
Financial values in the chart are available after Gm Pharma Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
15.15%▲
Total operating revenue
15.15%▲
Operating profit (EBIT)
50.48%▲
EBITDA
23.55%▲
Net Profit (Loss) for the Period
38.63%▲
Total assets
13.49%▲
Total equity
34.07%▲
Operating Profit Margin (ROS)
1.5%▲
Net Profit Margin
0.82%▲
Return on Equity (ROE)
0.83%▲
Quick Ratio
0.42%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo